Gujrathi Sheila

CIK 00015752026 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001575202

Recent Transactions

46 trades

Award
Janux Therapeutics, Inc.$JANX
Common Stock
2025-06-11+3,750→ 118,889 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2025-06-11+11,667→ 11,667 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2025-06-05+40,000→ 40,000 total
Purchase
Ventyx Biosciences, Inc.$VTYX
Common Stock
2024-12-23$2.31/sh+130,000→ 130,000 total
Other
Janux Therapeutics, Inc.$JANX
Common Stock
2024-11-05+4,611→ 115,139 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2024-06-26+8,350→ 8,350 total
Award
Janux Therapeutics, Inc.$JANX
Common Stock
2024-06-26+2,500→ 110,528 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2024-06-06+33,000→ 33,000 total
Other
Janux Therapeutics, Inc.$JANX
Common Stock
2024-02-29+2,986→ 108,028 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2024-01-21+80,000→ 80,000 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2023-06-14+12,500→ 12,500 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (right to buy)
2023-06-08+15,937→ 15,937 total
Exercise/Conversion
Ventyx Biosciences, Inc.$VTYX
Stock Option (Right to Buy)
2023-03-30−100,000→ 662,369 total
Exercise/Conversion
Ventyx Biosciences, Inc.$VTYX
Common Stock
2023-03-30$6.03/sh+100,000→ 100,000 total
Sale
Ventyx Biosciences, Inc.$VTYX
Common Stock
2023-03-30$33.73/sh−100,000→ 0 total
Gift
Ventyx Biosciences, Inc.$VTYX
Common Stock
2022-12-21−32,987→ 0 total
Award
Janux Therapeutics, Inc.$JANX
Stock Option (right to buy)
2022-06-14+12,500→ 12,500 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (right to buy)
2022-06-09+21,825→ 21,825 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (right to buy)
2022-06-09+13,301→ 13,301 total
Award
Ventyx Biosciences, Inc.$VTYX
Stock Option (right to buy)
2021-12-02+277,941→ 277,941 total
Conversion
Ventyx Biosciences, Inc.$VTYX
Common Stock
2021-10-25+32,897→ 32,897 total
Conversion
Ventyx Biosciences, Inc.$VTYX
Series A Preferred Stock
2021-10-25−32,897→ 0 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2020-06-15+8,500→ 8,500 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (right to buy)
2020-02-14+292,000→ 292,000 total
Award
Gossamer Bio, Inc.$GOSS
Common Stock
2020-02-14+189,500→ 189,500 total
Purchase
Gossamer Bio, Inc.$GOSS
Common Stock
2019-09-27$16.80/sh+10,000→ 4,048,242 total
Award
Turning Point Therapeutics, Inc.
Stock Option (right to buy)
2019-04-22+15,000→ 15,000 total
Award
Gossamer Bio, Inc.$GOSS
Stock Option (right to buy)
2019-03-25+380,000→ 380,000 total
Conversion
Gossamer Bio, Inc.$GOSS
Common Stock
2019-02-12+62,030→ 4,038,242 total
Conversion
Gossamer Bio, Inc.$GOSS
Series A Preferred Stock
2019-02-12−223,182→ 0 total
Conversion
Gossamer Bio, Inc.$GOSS
Series B Preferred Stock
2019-02-12−55,957→ 0 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2018-05-10+10,000→ 10,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2017-05-10+10,000→ 10,000 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2016-05-19+10,000→ 0 total
Award
FIVE PRIME THERAPEUTICS, INC.
Stock Option (right to buy)
2015-12-02+25,000→ 25,000 total
Disposition to Issuer
Receptos, Inc.
Employee Stock Option (right to buy)
2015-08-27$223.90/sh−26,666→ 0 total
Disposition to Issuer
Receptos, Inc.
Employee Stock Option (right to buy)
2015-08-27$190.49/sh−55,418→ 0 total
Disposition to Issuer
Receptos, Inc.
Common Stock
2015-08-27−12,500→ 0 total
Disposition to Issuer
Receptos, Inc.
Employee Stock Option (right to buy)
2015-08-27$213.23/sh−129,400→ 0 total
Disposition from Tender
Receptos, Inc.
Common Stock
2015-08-25−120,661→ 12,500 total
Award
Receptos, Inc.
Common Stock
2015-04-01+12,500→ 133,161 total
Sale
Receptos, Inc.
Common Stock
2014-11-11$108.99/sh−30,000→ 120,661 total
Sale
Receptos, Inc.
Common Stock
2014-09-22$61.45/sh−30,000→ 150,661 total
Award
Receptos, Inc.
Employee Stock Option (right to buy)
2013-07-17+129,400→ 129,400 total
Conversion
Receptos, Inc.
Common Stock
2013-05-14$5.25/sh+13,333→ 180,661 total
Conversion
Receptos, Inc.
Series A Preferred Stock
2013-05-14−100,000→ 0 total

Gujrathi Sheila

Recent Transactions

Companies

Recent Filings

Address